1-3 of 3
Giovanna Mattioli, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Kinetics of Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients May Predict Persistent Polymerase Chain Reaction Negativity after Imatinib Discontinuation.

Giovanna Rege-Cambrin, PhD, Stefano Ulisciani, MD, Giovanna Mattioli, MD, Carmen Fava, MD, Emilia Giugliano, BD, Vanessa Brunetto, BD, Enrico Gottardi, BD, Milena Fava, BD, Giuseppe Saglio, MD
Journal: Blood
Blood (2007) 110 (11): 1956.
https://doi.org/10.1182/blood.V110.11.1956.1956
Published: 2007
Journal Articles

A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.

Emilia Giugliano, BD, Dario Ferrero, MD, Carmen Fava, MD, Chiara Dellacasa, MD, Giovanna Mattioli, MD, Patrizia Scaravaglio, BD, Enrico Gottardi, Stefano Ulisciani, MD, Filomena Daraio, BD, Giuseppe Saglio, MD, Giovanna Rege-Cambrin, MD
Journal: Blood
Blood (2006) 108 (11): 4910.
https://doi.org/10.1182/blood.V108.11.4910.4910
Published: 2006
Journal Articles

Complete Reversion of Imatinib-Induced Hepatotoxicity in Chronic Myeloid Leukemia Patients by Low-Intermediate Dose Corticosteroid.

Dario Ferrero, MD, Enrico M. Pogliani, MD, Giovanna Rege-Cambrin, MD, Carmen Fava, MD, Giovanna Mattioli, MD, Chiara Dellacasa, MD, Valentina Giai, MD, Mariella Genuardi, Paola Perfetti, MD, Monica Fumagalli, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2005) 106 (11): 4856.
https://doi.org/10.1182/blood.V106.11.4856.4856
Published: 2005